TP53 and ovarian carcinoma: On the other hand, the findings of MTT assays on the two ovarian cancer cell lines harboring different p53 status suggested that the effect of FBI-1 on cell proliferation might be restricted in cells with intact p53 function, consistent with findings from a previous report [34].